These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 20412041)
1. Quantitative structure activity relationship (QSAR) analysis of substituted 4-oxothiazolidines and 5-arylidines as lipoxygenase inhibitors. Choudhary AN; Kumar A; Juyal V Mini Rev Med Chem; 2010 Jul; 10(8):705-14. PubMed ID: 20412041 [TBL] [Abstract][Full Text] [Related]
2. Lipoxygenase inhibitors: a comparative QSAR study review and evaluation of new QSARs. Pontiki E; Hadjipavlou-Litina D Med Res Rev; 2008 Jan; 28(1):39-117. PubMed ID: 17191217 [TBL] [Abstract][Full Text] [Related]
3. Review in quantitative structure activity relationships on lipoxygenase inhibitors. Eleni P; Dimitra HL Mini Rev Med Chem; 2003 Aug; 3(5):487-99. PubMed ID: 12769699 [TBL] [Abstract][Full Text] [Related]
4. QSAR study on 5-lipoxygenase inhibitors using distance-based topological indices. Agrawal VK; Bano S; Khadikar PV Bioorg Med Chem; 2003 Dec; 11(24):5519-27. PubMed ID: 14642596 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of benzo[1.3.2]dithiazolium ylide 1,1-dioxide derivatives as potential dual cyclooxygenase-2/5-lipoxygenase inhibitors. Tan CM; Chen GS; Chen CS; Chang PT; Chern JW Bioorg Med Chem; 2011 Nov; 19(21):6316-28. PubMed ID: 21958737 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and identification of novel substituted 2-amino thiazole analogues as potential anti-inflammatory agents targeting 5-lipoxygenase. Sinha S; Doble M; Manju SL Eur J Med Chem; 2018 Oct; 158():34-50. PubMed ID: 30199704 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and pharmacobiological evaluation of novel acrylic acid derivatives acting as lipoxygenase and cyclooxygenase-1 inhibitors with antioxidant and anti-inflammatory activities. Pontiki E; Hadjipavlou-Litina D; Litinas K; Nicolotti O; Carotti A Eur J Med Chem; 2011 Jan; 46(1):191-200. PubMed ID: 21106277 [TBL] [Abstract][Full Text] [Related]
8. Rational Use of Heterogeneous Data in Quantitative Structure-Activity Relationship (QSAR) Modeling of Cyclooxygenase/Lipoxygenase Inhibitors. Lagunin AA; Geronikaki A; Eleftheriou P; Pogodin PV; Zakharov AV J Chem Inf Model; 2019 Feb; 59(2):713-730. PubMed ID: 30688458 [TBL] [Abstract][Full Text] [Related]
9. Essential structural profile of a dual functional inhibitor against cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX): molecular docking and 3D-QSAR analyses on DHDMBF analogues. Zheng M; Zhang Z; Zhu W; Liu H; Luo X; Chen K; Jiang H Bioorg Med Chem; 2006 May; 14(10):3428-37. PubMed ID: 16458008 [TBL] [Abstract][Full Text] [Related]
10. QSAR by LFER model of HIV protease inhibitor mannitol derivatives using FA-MLR, PCRA, and PLS techniques. Leonard JT; Roy K Bioorg Med Chem; 2006 Feb; 14(4):1039-46. PubMed ID: 16213730 [TBL] [Abstract][Full Text] [Related]
11. Quantitative structure-activity relationships of 5-lipoxygenase inhibitors. Inhibitory potency of pyridazinone analogues. Kim KH; Martin YC; Brooks DW; Dyer RD; Carter GW J Pharm Sci; 1994 Mar; 83(3):433-8. PubMed ID: 8207697 [TBL] [Abstract][Full Text] [Related]
12. QSAR study on 5-lipoxygenase inhibitors based on support vector machine. Niu B; Su Q; Yuan X; Lu W; Ding J Med Chem; 2012 Nov; 8(6):1108-16. PubMed ID: 22779798 [TBL] [Abstract][Full Text] [Related]
13. Substituted furans as potent lipoxygenase inhibitors: Synthesis, in vitro and molecular docking studies. Vinayagam J; Gajbhiye RL; Mandal L; Arumugam M; Achari A; Jaisankar P Bioorg Chem; 2017 Apr; 71():97-101. PubMed ID: 28143657 [TBL] [Abstract][Full Text] [Related]
14. QSAR study for the soybean 15-lipoxygenase inhibitory activity of organosulfur compounds derived from the essential oil of garlic. Camargo AB; Marchevsky E; Luco JM J Agric Food Chem; 2007 Apr; 55(8):3096-103. PubMed ID: 17367159 [TBL] [Abstract][Full Text] [Related]
15. QSAR analyses of 3-(4-benzylpiperidin-1-yl)-N-phenylpropylamine derivatives as potent CCR5 antagonists. Roy K; Leonard JT J Chem Inf Model; 2005; 45(5):1352-68. PubMed ID: 16180912 [TBL] [Abstract][Full Text] [Related]
16. Fragment-based design, docking, synthesis, biological evaluation and structure-activity relationships of 2-benzo/benzisothiazolimino-5-aryliden-4-thiazolidinones as cycloxygenase/lipoxygenase inhibitors. Eleftheriou P; Geronikaki A; Hadjipavlou-Litina D; Vicini P; Filz O; Filimonov D; Poroikov V; Chaudhaery SS; Roy KK; Saxena AK Eur J Med Chem; 2012 Jan; 47(1):111-24. PubMed ID: 22119153 [TBL] [Abstract][Full Text] [Related]
17. Design of a novel thiophene inhibitor of 15-lipoxygenase-1 with both anti-inflammatory and neuroprotective properties. Eleftheriadis N; Poelman H; Leus NGJ; Honrath B; Neochoritis CG; Dolga A; Dömling A; Dekker FJ Eur J Med Chem; 2016 Oct; 122():786-801. PubMed ID: 27477687 [TBL] [Abstract][Full Text] [Related]
18. Pteridine-2,4-diamine derivatives as radical scavengers and inhibitors of lipoxygenase that can possess anti-inflammatory properties. Pontiki E; Hadjipavlou-Litina D; Patsilinakos A; Tran TM; Marson CM Future Med Chem; 2015; 7(14):1937-51. PubMed ID: 26423719 [TBL] [Abstract][Full Text] [Related]
19. Design of more potent squalene synthase inhibitors with multiple activities. Kourounakis AP; Matralis AN; Nikitakis A Bioorg Med Chem; 2010 Nov; 18(21):7402-12. PubMed ID: 20888243 [TBL] [Abstract][Full Text] [Related]